Table 5.
Absolute reduction in 35 day mortality associated with the use of thrombolytic therapy in patients with ‘suspected’ acute myocardial infarction. Adapted from the Fibrinolytic Therapy Trialists’ Collaborative Group [13].

Absolute reduction in 35 day mortality associated with the use of thrombolytic therapy in patients with ‘suspected’ acute myocardial infarction. Adapted from the Fibrinolytic Therapy Trialists’ Collaborative Group [13].
